Drug intelligence / Profile preview

Sinarest Vapocap

Development stage
Unknown
Lead developer
Centaur Pharmaceuticals
Modality
Small Molecules
Administration
Inhalation
01

Overview

Sinarest Vapocap is an approved, over-the-counter inhalant decongestant capsule developed and marketed by Centaur Pharmaceuticals. It is a multi-ingredient, small molecule formulation containing camphor, chlorothymol, eucalyptol (eucalyptus oil), menthol, and terpineol. Delivered via steam inhalation or by applying the capsule contents to a cloth or pillow, it is indicated for the relief of nasal congestion, common cold, allergic rhinitis, sinusitis, pharyngitis, and upper respiratory tract congestion. The active ingredients release soothing aromatic vapors that help clear nasal passages, thin mucus, and ease breathing. Menthol and eucalyptol provide a cooling sensation by activating cold-sensitive receptors, while camphor acts as a mild analgesic and rubefacient, and chlorothymol and terpineol provide antiseptic and anti-infective properties.

Brand names
Sinarest VapocapSinarest Vapocaps
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Sinarest Vapocap.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinarest Vapocap.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call